Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 3490.

https://doi.org/10.1182/blood-2023-186636

Published: 2023

Journal Articles

B-Lymphoblastic Leukemia Presenting with Eosinophilia: A Case Report and Review

David Shabsovich, Michael J. Maranzano, Jonathan Said, Nam Ku, Sheeja Pullarkat, Gary J. Schiller

Blood (2023) 142 (Supplement 1): 6059.

https://doi.org/10.1182/blood-2023-181232

Published: 2023

Journal Articles

Sclerosing angiomatoid nodular transformation of the spleen

Jonathan Said, Robin Dietz

Blood (2021) 137 (17): 2417.

https://doi.org/10.1182/blood.2021011137

Published: 2021

Journal Articles

Severe mosquito bite allergy: an unusual EBV + NK cell lymphoproliferative disorder

Jonathan Said, Chandra Smart

Blood (2019) 133 (9): 999.

https://doi.org/10.1182/blood-2018-11-886341

Published: 2019

Journal Articles

Intraocular toxoplasmosis mimicking vitreous lymphoma

Ruijun Jeanna Su, Jonathan Said

Blood (2019) 133 (7): 767.

https://doi.org/10.1182/blood-2018-10-883124

Published: 2019

Journal Articles

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Yasodha Natkunam, Dita Gratzinger, Amy Chadburn, John R. Goodlad, John K. C. Chan, Jonathan Said, Elaine S. Jaffe, Daphne de Jong

Blood (2018) 132 (18): 1871–1878.

https://doi.org/10.1182/blood-2018-04-842559

Published: 2018

Journal Articles

Multicentric Castleman disease: consensus at last?

Jonathan Said

Blood (2017) 129 (12): 1569–1570.

https://doi.org/10.1182/blood-2017-01-763482

Published: 2017

Journal Articles

The expanding spectrum of EBV + lymphomas

Jonathan Said

Blood (2015) 126 (7): 827–828.

https://doi.org/10.1182/blood-2015-06-648097

Published: 2015

Journal Articles

C/EBPε Plays a Role in Immunity By Regulating Trem-1 Expression in Granulocytes

Hyung Chan Suh, MDPhD, Tong Yin, MDPhD, Touati Benoukraf, PhD, Jonathan Said, MD, Stephen Lee, MD, Phillip Koeffler, MD

Blood (2014) 124 (21): 4100.

https://doi.org/10.1182/blood.V124.21.4100.4100

Published: 2014

Journal Articles

T-cell LPD of the GIT: first do no harm

Jonathan Said

Blood (2013) 122 (22): 3548–3550.

https://doi.org/10.1182/blood-2013-09-526368

Published: 2013

Journal Articles

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

June H. Myklebust, Jonathan M. Irish, Joshua Brody, Debra K. Czerwinski, Roch Houot, Holbrook E. Kohrt, John Timmerman, Jonathan Said, Michael R. Green, Jan Delabie, Arne Kolstad, Ash A. Alizadeh, Ronald Levy

Blood (2013) 121 (8): 1367–1376.

https://doi.org/10.1182/blood-2012-04-421826

Published: 2013

Includes: Supplemental data

Journal Articles

Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death

Mary C. Clark, Mabel Pang, Daniel K. Hsu, Fu-Tong Liu, Sven de Vos, Randy D. Gascoyne, Jonathan Said, Linda G. Baum

Blood (2012) 120 (23): 4635–4644.

https://doi.org/10.1182/blood-2012-06-438234

Published: 2012

Includes: Supplemental data

Journal Articles

Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-Cell Lymphomas: A North American PTCL Study Group Project

Eric D. Hsi, MD, Jonathan Said, MD, William R Macon, MD, Scott J. Rodig, MD, PhD, Randy D. Gascoyne, MD, Sarah Ondrejka, MD, David Dorfman, MD, PhD, Elizabeth A. Morgan, MD, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD

Blood (2012) 120 (21): 1545.

https://doi.org/10.1182/blood.V120.21.1545.1545

Published: 2012

Journal Articles

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

Haiming Chen, Richard A. Campbell, Yunchao Chang, Mingjie Li, Cathy S. Wang, Jennifer Li, Eric Sanchez, Michael Share, Jeffrey Steinberg, Ariana Berenson, Dror Shalitin, Zhaohui Zeng, Dorina Gui, Pablo Perez-Pinera, Ronald J. Berenson, Jonathan Said, Benjamin Bonavida, Thomas F. Deuel, James R. Berenson

Blood (2009) 113 (9): 1992–2002.

https://doi.org/10.1182/blood-2008-02-133751

Published: 2009

Journal Articles

Expression of Circadian Core Clock Gene Per2 Is Markedly Down-Regulated in Diffuse Large B-Cell Lymphoma

Nils Heinrich Thoennissen, Qi Cao, BaoNgan Doan, Sam Abbassi, Daniel Nowak, C. Müller-Tidow, MD, Jonathan Said, MD, Sigal Gary, H. Phillip Koeffler, MD

Blood (2008) 112 (11): 4470.

https://doi.org/10.1182/blood.V112.11.4470.4470

Published: 2008

Journal Articles

Spectrum of Expression and Biological Activity of Programmed Death Ligand 1 (PD-L1) in Non-Hodgkin’s Lymphomas

David J Andorsky, MD, Reiko Yamada, Kristopher K Steward, BS, Sven De Vos, MD, PhD, Jonathan Said, John M Timmerman, MD

Blood (2008) 112 (11): 4140.

https://doi.org/10.1182/blood.V112.11.4140.4140

Published: 2008

Journal Articles

Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study

Eric D Hsi, MD, Jonathan Said, Jeffrey L Johnson, Sinho Jung, Raymond Lai, MD, Dan Jones, MD, PhD, Amy Chadburn, MD, Bruce D. Cheson, MD, Wyndham H. Wilson

Blood (2008) 112 (11): 476.

https://doi.org/10.1182/blood.V112.11.476.476

Published: 2008

Journal Articles

Follicular lymphomas and histiocytic/dendritic neoplasms related?

Jonathan Said

Blood (2008) 111 (12): 5418–5419.

https://doi.org/10.1182/blood-2008-02-140962

Published: 2008

Journal Articles

A Pilot Trial of Valproic Acid in Patients with Kaposi’s Sarcoma: A Multi-Center Trial of the AIDS Malignancy Consortium.

Mary Jo Lechowicz, MD, Jeannette Lee, Ph.D, Dirk Dittmer, Ph.D, Susan Krown, MD, Jonathan Said, MD, Richard F. Ambinder, MD, Ph.D

Blood (2007) 110 (11): 2279.

https://doi.org/10.1182/blood.V110.11.2279.2279

Published: 2007

Journal Articles

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 2520.

https://doi.org/10.1182/blood.V110.11.2520.2520

Published: 2007

NARROW

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

B-Lymphoblastic Leukemia Presenting with Eosinophilia: A Case Report and Review

Sclerosing angiomatoid nodular transformation of the spleen

Severe mosquito bite allergy: an unusual EBV + NK cell lymphoproliferative disorder

Intraocular toxoplasmosis mimicking vitreous lymphoma

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Multicentric Castleman disease: consensus at last?

The expanding spectrum of EBV + lymphomas

C/EBPε Plays a Role in Immunity By Regulating Trem-1 Expression in Granulocytes

T-cell LPD of the GIT: first do no harm

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death

Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-Cell Lymphomas: A North American PTCL Study Group Project

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

Expression of Circadian Core Clock Gene Per2 Is Markedly Down-Regulated in Diffuse Large B-Cell Lymphoma

Spectrum of Expression and Biological Activity of Programmed Death Ligand 1 (PD-L1) in Non-Hodgkin’s Lymphomas

Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study

Follicular lymphomas and histiocytic/dendritic neoplasms related?

A Pilot Trial of Valproic Acid in Patients with Kaposi’s Sarcoma: A Multi-Center Trial of the AIDS Malignancy Consortium.

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only